Zenas BioPharma, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | $10.0 | $5.0 | $50.0 | — |
| Operating income | -$383.1 | -$163.9 | -$37.1 | — |
| Net income | -$377.7 | -$157.0 | -$37.1 | — |
| Cash Flow Statement | ||||
| Free cash flow | -$172.4 | -$119.8 | -$30.5 | — |
Shares outstanding 65.2M · Free float 42.6%
Annual filing data through FY ended December 31, 2025; float as of September 14, 2026.